AtriCure, Inc. — Director's Dealing 2020

Jan 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-01-02

Reporting Person: Noznesky Justin J (SVP, Mktg & Business Develop)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-02	Common Stock	M	15000	$18.30	Acquired	106568	Direct
2020-01-02	Common Stock	S	15000	$32.89	Disposed	91568	Direct
2020-01-02	Common Stock	S	14134	$32.89	Disposed	77434	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Stock Option (right to buy)	$18.30	M	15000	Disposed	2024-01-06	Common Stock (15000)	Direct

Footnotes

F1: These shares were exercised pursuant to a 10b5-1 trading plan.

F2: These shares were sold pursuant to a 10b5-1 trading plan.

F3: This transaction was executed in multiple trades at prices ranging from $32.60 to $33.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $32.57 to $33.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.